The acquisition of Albireo and the integration of over 25 new programs into our pipeline since 2020 will enable us
Category: General
Ipsen’s partnership with Marengo
Ipsen’s 2022 Integrated Annual Report now available
2022 was a year of focus, momentum and growth at Ipsen. Learn about the progress we made and download the
Applications now open for the 2023 Golden Ticket Competition
As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition
Ipsen anti-corruption system certification renewed in 2022
In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance, a certification organization dedicated to
Ipsen becomes a founding sponsor of the second Biolabs innovation hub in Europe at Hopital Hotel Dieu, AP-HP
Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub in Europe at Hopital Hotel
Ipsen receives SBTi approval for climate targets
In October 2021, Ipsen pledged ambitious action on climate change. Today, we announce that Ipsen’s Climate Targets were approved by
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
A message from CEO David Loew
Hear what CEO David Loew has to say about our H1 2022 results.
How to transform the medical organization in specialty care to drive best-in-class patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer Medical affairs play a central role at Ipsen, where our strategy